Plans continue to open more pop-up vaccine sites in high-need areas despite J&J supply deficiency

As the U.S. Food and Drug Administration investigates reports of rare but potentially dangerous blood clots connected to the Johnson & Johnson Vaccine, the local effort to continue prioritizing low-income and minority neighborhoods is not facing any major disruptions due to the supply deficit.